| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.18▼ | 1.17▼ | 1.19▼ | 1.25▼ | 1.37▼ |
| MA10 | 1.17▼ | 1.20▼ | 1.21▼ | 1.32▼ | 1.47▼ |
| MA20 | 1.17▼ | 1.21▼ | 1.22▼ | 1.43▼ | 1.26▼ |
| MA50 | 1.20▼ | 1.25▼ | 1.29▼ | 1.48▼ | 0.98▲ |
| MA100 | 1.22▼ | 1.29▼ | 1.39▼ | 1.25▼ | 1.08▲ |
| MA200 | 1.23▼ | 1.40▼ | 1.50▼ | 1.00▲ | 1.29▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.006▼ | -0.003▼ | -0.038▼ | -0.027▼ |
| RSI | 32.974▼ | 32.037▼ | 31.068▼ | 27.089▼ | 47.416▼ |
| STOCH | 80.000 | 9.550▼ | 32.146 | 14.688▼ | 40.949 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -81.522▼ |
| CCI | -35.206 | -104.308▼ | -153.901▼ | -131.863▼ | -48.645 |
|
Wednesday, November 12, 2025 12:00 PM
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) reported third-quarter 2025 financial results and provided an update on its advancing portfolio of late-stage gene therapies for inherited retinal diseases.
|
|
Sunday, November 09, 2025 05:17 PM
Ocugen Inc (OCGN) progresses with key clinical trials and strategic partnerships, despite a decrease in cash reserves and rising operating expenses.
|
|
Thursday, November 06, 2025 05:30 AM
Q3 2025 Earnings Call Transcript November 5, 2025 Ocugen, Inc. misses on earnings expectations. Reported EPS is $-0.06596 EPS, expectations were $-0.0575. Operator: Good morning, and welcome to Ocugen ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/11/25 | 1.205 | 1.27 | 1.15 | 1.15 | 4,008,074 |
| 14/11/25 | 1.17 | 1.24 | 1.17 | 1.19 | 3,104,200 |
| 13/11/25 | 1.33 | 1.33 | 1.20 | 1.24 | 4,421,400 |
| 12/11/25 | 1.34 | 1.35 | 1.31 | 1.34 | 2,057,600 |
| 11/11/25 | 1.32 | 1.35 | 1.305 | 1.33 | 2,279,500 |
| 10/11/25 | 1.40 | 1.42 | 1.30 | 1.35 | 4,031,900 |
| 07/11/25 | 1.35 | 1.38 | 1.25 | 1.36 | 6,109,800 |
| 06/11/25 | 1.40 | 1.43 | 1.35 | 1.38 | 3,375,500 |
| 05/11/25 | 1.49 | 1.49 | 1.32 | 1.41 | 5,590,000 |
| 04/11/25 | 1.50 | 1.525 | 1.42 | 1.43 | 3,451,800 |
|
|
||||
|
|
||||
|
|